Tavakoli Mohammadbagher, Moghareabed Reza, Taheri Hossein, Dehkordy Mahta Noorbakhsh, Nasri Elaheh, Saeb Mohsen, Hemati Simin
Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Radiotherapy and Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Adv Biomed Res. 2024 Oct 28;13:92. doi: 10.4103/abr.abr_75_23. eCollection 2024.
The goal of this study was to assess the impact of deep local hyperthermia on oxygen (O) saturation and infected volumes of lungs on coronavirus disease 2019 (COVID-19) cancer patients.
Fifty patients who suffered from COVID-19 (according to their computed tomography (CT) images and laboratory findings) were included in this study. The mentioned patients were divided into two groups (I and II) with thirty-five participants. The infected volumes and COVID-19 infectious locations were diagnosed using their CT images, and deep local hyperthermia was performed for group II. After three consequent days, the SPO D-dimer, and infected volumes of lung parenchyma of both groups were compared to each other.
For group II, the mean ± SD (standard deviation) of O pressure saturation (SPO) before/after hyperthermia was 85 ± 0.0/91.3 ± 0.5, respectively, while for group I, the mean ± SD of SPO before/after 3 days was 85 ± 0.0/88 ± 0.2, respectively. For infected volumes of lungs before/after hyperthermia in group II, the mean ± SD was 31.36 ± 3.13/4 ± 1.53, respectively. Nonetheless, the infected volumes of lungs for group I were 34.21 ± 3.41/10 ± 2.12 before/after three days. For group II, the amount of D-dimer before/after hyperthermia was 3200 ± 106/510 ± 121, respectively. However, for group I, it was 3100/740 before/after the consequent three days, respectively.
Deep local lung hyperthermia for COVID-19 cancer patients is suggested, as a result of its positive impacts on SPO improvement and also D-dimer serum level, C-reactive protein, and Lactate dehydrogenaze reduction for the mentioned patients.
本研究的目的是评估深部局部热疗对2019冠状病毒病(COVID-19)癌症患者的血氧(O)饱和度及肺部感染体积的影响。
本研究纳入了50例COVID-19患者(根据其计算机断层扫描(CT)图像和实验室检查结果)。上述患者被分为两组(I组和II组),每组25名参与者。通过CT图像诊断感染体积和COVID-19感染部位,并对II组进行深部局部热疗。连续三天后,比较两组的血氧饱和度(SPO)、D-二聚体及肺实质感染体积。
II组热疗前后血氧分压饱和度(SPO)的平均值±标准差(SD)分别为85±0.0/91.3±0.5,而I组三天前后SPO的平均值±标准差分别为85±0.0/88±0.2。II组热疗前后肺部感染体积的平均值±标准差分别为31.36±3.13/4±1.53。然而,I组三天前后肺部感染体积分别为34.21±3.41/10±2.12。II组热疗前后D-二聚体的量分别为3200±106/510±121。然而,I组在随后三天前后分别为3100/740。
建议对COVID-19癌症患者进行深部局部肺部热疗,因为它对上述患者的SPO改善以及D-二聚体血清水平、C反应蛋白和乳酸脱氢酶降低有积极影响。